PriceTargets.com logo

Sonova - SONVY Stock Price Target and Predictions

  • Consensus Rating: Reduce
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 2
  • Breakdown:
  • 1 Sell Ratings
  • 1 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$56.35 As of 04/26/2024 06:13 PM ET
▲ +1.07 (1.94%)

This chart shows the closing price for SONVY by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Sonova Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SONVY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SONVY

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 2 analysts offering 12 month price targets for Sonova in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $56.35.

This chart shows the closing price for SONVY for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Reduce

The current consensus among 2 contributing investment analysts is to reduce stock in Sonova. This Reduce consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
11/3/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
2/1/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
5/2/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
7/31/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
10/29/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
1/27/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
3/27/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
4/26/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
5/17/2023JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral
5/12/2023Sanford C. BernsteinInitiated CoverageUnderperform
1/25/2023Jefferies Financial GroupDowngradeBuy ➝ Underperform
12/12/2022CitigroupInitiated CoverageSell
11/22/2022BarclaysBoost TargetCHF 290 ➝ CHF 330
10/18/2022Deutsche Bank AktiengesellschaftLower TargetHold ➝ HoldCHF 291 ➝ CHF 260
10/18/2022Morgan StanleyInitiated CoverageEqual Weight
10/18/2022Credit Suisse GroupDowngradeOutperform ➝ Neutral
9/13/2022BarclaysInitiated CoverageOverweight
8/29/2022Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold
7/27/2022Oddo BhfDowngradeOutperform ➝ Neutral
5/23/2022Deutsche Bank AktiengesellschaftLower TargetCHF 435 ➝ CHF 380
5/23/2022Credit Suisse GroupLower TargetCHF 415 ➝ CHF 380
5/18/2022JPMorgan Chase & Co.Lower TargetCHF 399 ➝ CHF 346
4/21/2022Jefferies Financial GroupInitiated CoverageHold
1/7/2022Exane BNP ParibasDowngradeNeutral ➝ Underperform
11/17/2021Credit Suisse GroupReiterated RatingOutperform
11/12/2021Oddo BhfUpgradeNeutral ➝ Outperform
10/7/2021UBS GroupReiterated RatingNeutral
9/16/2021Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy
6/8/2021Morgan StanleyReiterated RatingEqual Weight
6/3/2021Berenberg BankReiterated RatingHold
5/21/2021UBS GroupReiterated RatingNeutral
5/19/2021Credit Suisse GroupReiterated RatingOutperform
5/19/2021Deutsche Bank AktiengesellschaftReiterated RatingHold
5/19/2021JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight
5/19/2021The Goldman Sachs GroupUpgradeSell ➝ Neutral
3/24/2021JPMorgan Chase & Co.Reiterated RatingNeutral
2/18/2021Exane BNP ParibasUpgradeUnderperform ➝ Outperform
2/2/2021UBS GroupReiterated RatingNeutral
12/9/2020Morgan StanleyReiterated RatingEqual Weight
12/1/2020Jefferies Financial GroupUpgradeHold ➝ Buy
11/24/2020JPMorgan Chase & Co.Reiterated RatingNeutral
11/23/2020Berenberg BankReiterated RatingHold
11/17/2020Credit Suisse GroupReiterated RatingOutperform
11/17/2020UBS GroupReiterated RatingNeutral
11/5/2020Berenberg BankReiterated RatingHold
10/8/2020Credit Suisse GroupReiterated RatingOutperform
10/8/2020CitigroupInitiated CoverageNeutral
9/30/2020JPMorgan Chase & Co.Reiterated RatingNeutral
9/29/2020Deutsche Bank AktiengesellschaftReiterated RatingHold
9/29/2020UBS GroupReiterated RatingNeutral
9/2/2020UBS GroupReiterated RatingNeutral
7/27/2020Morgan StanleyUpgradeUnderweight ➝ Equal Weight
5/22/2020UBS GroupDowngradeBuy ➝ Neutral
5/21/2020JPMorgan Chase & Co.UpgradeNeutral
5/20/2020Deutsche Bank AktiengesellschaftReiterated RatingHold
5/12/2020Berenberg BankReiterated RatingHold
4/17/2020JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral
4/9/2020Jefferies Financial GroupDowngradeBuy ➝ Hold
1/5/2020JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight
10/31/2019The Goldman Sachs GroupDowngradeNeutral ➝ Sell
9/10/2019Jefferies Financial GroupUpgradeHold ➝ Buy
(Data available from 4/26/2019 forward)

News Sentiment Rating

1.08 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/29/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/29/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
11/28/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/28/2023
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/27/2024
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/26/2024
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/27/2024
  • 2 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/26/2024

Current Sentiment

  • 2 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Sonova logo
Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands. The Cochlear Implants segment is involved in the design, development, manufacture, distribution, and service of hearing implants and related products under the Advanced Bionics brand. The company sells its products through independent distributors; and provides hearing care services through a network of stores and clinics. The company was formerly known as Phonak Holding AG and changed its name to Sonova Holding AG in August 2007. Sonova Holding AG was founded in 1947 and is headquartered in Stäfa, Switzerland.
Read More

Today's Range

Now: $56.35
Low: $56.08
High: $56.49

50 Day Range

MA: $59.87
Low: $54.23
High: $65.88

52 Week Range

Now: $56.35
Low: $45.54
High: $66.13

Volume

10,843 shs

Average Volume

10,778 shs

Market Capitalization

$16.80 billion

P/E Ratio

N/A

Dividend Yield

1.10%

Beta

1.14

Frequently Asked Questions

What sell-side analysts currently cover shares of Sonova?

The following Wall Street sell-side analysts have issued reports on Sonova in the last twelve months: JPMorgan Chase & Co., and Sanford C. Bernstein.
View the latest analyst ratings for SONVY.

What is the current price target for Sonova?

0 Wall Street analysts have set twelve-month price targets for Sonova in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Sonova in the next year.
View the latest price targets for SONVY.

What is the current consensus analyst rating for Sonova?

Sonova currently has 1 sell rating and 1 hold rating from Wall Street analysts. The stock has a consensus analyst rating of "Reduce."
View the latest ratings for SONVY.

What other companies compete with Sonova?

Other companies that are similar to Sonova include Masimo, Fresenius SE & Co. KGaA, Astellas Pharma, BioMarin Pharmaceutical and Avantor. Learn More about companies similar to Sonova.

How do I contact Sonova's investor relations team?

Sonova's physical mailing address is Laubisrutistrasse 28, Stafa V8, 8712. The company's listed phone number is (158) 928-0101 and its investor relations email address is [email protected]. The official website for Sonova is www.sonova.com. Learn More about contacing Sonova investor relations.